CMTA Advances Drug Repurposing with an Additional $225,720 Investment in CMT1B and CMT1E Research
Project extends ongoing CMTA-funded research in CMT1A that targets protein-clearance machinery to restore peripheral nerve function. GLENOLDEN, PA, UNITED STATES, August 11, 2026 /EINPresswire.com/ -- The Charcot-Marie-Tooth Association (CMTA) announced …